# US 2026/0158291 A1 · Therapeutic devices and methods for treating corneal abrasions, corneal infections, and prophylaxis of corneal infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0158291 A1
- Document ID: US20260158291A1
- Status: Published application
- Kind: A1
- Application number: 19/454,958
- Filed: 2026-01-21
- Published: 2026-06-11
- Earliest claimed: 2024-12-11
- Assignees: KeraLink International, Inc.
- Applicants: KeraLink International, Inc.
- Inventors: David Green; Aaron Chang; Alexandra Sibole; Ryan Chase Kelley
- Web page: https://patentgrep.com/patent/US20260158291A1

## CPC

- A61N 5/0624: {for eliminating microbes, germs, bacteria on or in the body}
- A61B 3/0008: {provided with illuminating means (A61B3/117, A61B3/14 take precedence)}
- A61B 3/0025: {characterised by electronic signal processing, e.g. eye models}
- A61B 3/14: Arrangements specially adapted for eye photography
- A61N 5/067: using laser light
- A61N 2005/0627: {Dose monitoring systems and methods}
- A61N 2005/063: {comprising light transmitting means, e.g. optical fibres}
- A61N 2005/0644: {Handheld applicators}
- A61N 2005/0652: {Arrays of diodes}
- A61N 2005/0659: {infrared}
- A61N 2005/0661: {ultraviolet}
- A61N 2005/0662: {Visible light}
- A61N 2005/0666: {for redirecting light to the treatment area}
- A61N 2005/0667: {Filters}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present disclosure relates to a therapeutic device for treating a corneal abrasion, a corneal infection, or both, where the therapeutic device includes a housing including an eye module, a camera module mounted in the housing and configured to detect light from the eye module, a non-ultraviolet light source configured to direct non-ultraviolet light through the eye module. A benefit of the devices can be to provide targeted, dynamically adaptable treatments to eyes afflicted with corneal abrasions and corneal infections.

## Claims

### Claim 1

A therapeutic device for treating a corneal abrasion, a corneal infection, or prophylaxis of a corneal infection, or any combination thereof, comprising:
a housing including an eye module;
a camera module mounted in the housing and configured to detect light from the eye module;
a non-ultraviolet light source configured to direct non-ultraviolet light through the eye module; and
an ultraviolet light source configured to direct ultraviolet light through the eye module at an ultraviolet wavelength, an ultraviolet intensity, and an ultraviolet angle of incidence,
wherein the ultraviolet light source is configured to change the ultraviolet wavelength within an ultraviolet range of from about 200 nm to about 300 nm, to change the ultraviolet intensity within an ultraviolet intensity range of from about 2.0 mJ/cm2 to about 1,500mJ/cm2, or to change the ultraviolet angle of incidence within an ultraviolet angle range of from 0° to 90°, or any combination thereof.

### Claim 2 (depends on 1)

The therapeutic device of claim 1, wherein the eye module is located on an exterior of the housing and includes a light source opening surrounded by an eye adapter,
wherein the eye adapter has a ring shape with a raised lip surrounding an eye adapter recess, wherein the eye adapter recess surrounds the light source opening; and
wherein the raised lip has a lip diameter or a lip longest distance across the eye adapter of from about 40.0 mm to about 60.0 mm; or
wherein the eye adapter recess has an eye adapter depth of about 1.0 cm to about 5.0 cm from the raised lip to the light source opening; or
wherein the therapeutic device has a device weight of about 227.0 g to about 1,360.0 g.

### Claim 3 (depends on 1)

The therapeutic device of claim 1, further comprising:
a UV mirror, wherein the UV mirror includes a dichroic mirror or a metal-containing mirror,
wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes, an excimer lamp, a laser, or a combination thereof;
wherein the UV mirror is configured to direct non-ultraviolet light from the non-ultraviolet light source through the eye module; or
wherein the UV mirror is configured to direct the ultraviolet light from the ultraviolet light source through the eye module; or
wherein the UV mirror is configured to simultaneously direct non-ultraviolet light from the non-ultraviolet light source and the ultraviolet light from the ultraviolet light source through the eye module; or
wherein the UV mirror is located between the eye module and the camera module; or
wherein the UV mirror is located between the eye module and the ultraviolet light source; or
wherein the housing contains an actuator adjustable focal lens, a frequency doubler, a triple filter, one or more rotatable filters, a mechanically rotatable filter, or an aperture, or a combination thereof, located between the eye module and the ultraviolet light source, and
one or more of the actuator adjustable focal lens, the frequency doubler, the triple filter, one or more rotatable filters, the mechanically rotatable filter, the aperture, or the combination thereof, are configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof; or
wherein the housing contains an actuator a frequency doubler, a mechanically rotatable filter, or both, located between the eye module and the non-ultraviolet light source, and configured to convert the non-ultraviolet light into the ultraviolet light; or
any combination thereof.

### Claim 4 (depends on 1)

The therapeutic device of claim 1, wherein the eye module includes an array of optical fibers,
wherein the array of optical fibers is operatively connected to the ultraviolet light source,
wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes, an excimer lamp, a laser, or a combination thereof;
wherein emitting portions of the array of optical fibers are mounted around an eye adapter interior surface of the eye module;
wherein an eye module actuator is operatively connected to the eye adapter, the emitting portions, or any combination thereof; and
wherein the eye module actuator is configured to change the ultraviolet angle of incidence from the emitting portions by moving the emitting portions along the eye module interior surface; or
wherein the eye module actuator is configured to change the ultraviolet angle of incidence from the emitting portions by moving the eye adapter; or
wherein the eye module contains one or more movable reflectors capable of changing the angle of incidence relative to the emitting portions;
or any combination thereof.

### Claim 5 (depends on 1)

The therapeutic device of claim 1, wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes mounted around an eye adapter interior surface of the eye module,
wherein an ultraviolet light emitting diode of the array of ultraviolet light emitting diodes is mounted on an actuator track, and
wherein the ultraviolet light emitting diode is configured to change the ultraviolet angle of incidence by moving the ultraviolet light emitting diode along the actuator track; or
wherein two or more ultraviolet light emitting diodes of the array of ultraviolet light emitting diodes are mounted on an actuator track, and the two or more ultraviolet light emitting diodes are configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, by turning on or off.

### Claim 6 (depends on 1)

The therapeutic device of claim 1, wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes mounted around an eye adapter interior surface of the eye module,
wherein two or more ultraviolet light emitting diodes of the array of ultraviolet light emitting diodes are configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, by turning on or off.

### Claim 7 (depends on 1)

The therapeutic device of claim 1, wherein the housing contains a camera module opening surrounding a lens of the camera module, and
wherein the non-ultraviolet light source includes a visible light emitting diode, an infrared light emitting diode, an array of visible light emitting diodes, an array infrared light emitting diodes, or a combined array of visible light emitting diodes and infrared light emitting diodes, or any combination thereof; or
wherein the non-ultraviolet light source includes a visible light emitting diode capable of emitting light at a visible wavelength of from about 400 nm to about 700 nm; or
wherein the non-ultraviolet light source includes an infrared light emitting diode capable of emitting an infrared light at a wavelength of from about 780 nm to about 1,000 nm; or
wherein the non-ultraviolet light source is located adjacent to a lens of the camera module; or
wherein the non-ultraviolet light source includes an array of visible light emitting diodes adjacent to or round a lens of the camera module;
wherein the non-ultraviolet light source includes an array of infrared light emitting diodes adjacent to or round a lens of the camera module; or
any combination thereof.

### Claim 8 (depends on 1)

The therapeutic device of claim 1,
wherein the housing contains a processor,
wherein the processor is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof, and
wherein the processor is configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.1 second to about 2.0 minutes by executing a computer readable code; or
wherein the housing contains a processor,
wherein the processor is operatively connected to a control panel located on the device exterior, or wherein the processor is operatively connected to at least one communication link, or any combination thereof,
wherein the communication link includes a short-range wireless connection, a universal serial bus (USB) connection, or a data port; or
wherein the camera module includes a charged coupled device or a complementary metal oxide semiconductor (CMOS) image sensor; or a camera lens configured to focus light at a distance of from about 1.0 cm to about 25.0 cm from a surface of the camera lens; or the camera module includes a light transparent protective cover between a surface of the camera lens and the eye module; or
wherein the housing contains the ultraviolet light source and the non-ultraviolet light source and one or both of the ultraviolet light source and the non-ultraviolet light source are configured to move along a track or to change ultraviolet intensity or both; or
any combination thereof.

### Claim 9

A method of detecting or treating a corneal abrasion, a corneal infection, or prophylaxis of a corneal infection, or any combination thereof, in a subject in need thereof, comprising:
providing a therapeutic device, wherein the therapeutic device includes, a housing including an eye module; a camera module mounted in the housing and configured to detect light from the eye module; a non-ultraviolet light source configured to direct non-ultraviolet light through the eye module; and an ultraviolet light source configured to direct ultraviolet light through the eye module at an ultraviolet wavelength, an ultraviolet intensity, and an ultraviolet angle of incidence, wherein the ultraviolet light source is configured to change the ultraviolet wavelength within an ultraviolet range of from about 200 nm to about 300 nm, to change the ultraviolet intensity within an ultraviolet intensity range of from about 2.0 mJ/cm2 to about 1,500 mJ/cm2, or to change the ultraviolet angle of incidence within an ultraviolet angle range of from 0° to 90°, or any combination thereof, and
directing the ultraviolet light into the eye of the subject at the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, for a therapeutic duration.

### Claim 10 (depends on 9)

The method of claim 9, wherein the therapeutic duration is from about 1.0 second to about 5.0 minutes; or
further comprising, changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.1 second to about 2.0 minutes before, during, or after the therapeutic duration; or
wherein the subject is a human being or a mammal.

### Claim 11 (depends on 9)

The method of claim 9, further comprising:
before, during, or after directing the ultraviolet light into the eye of the subject, reducing inflammation or microbial burden; or treating a wound by directing the non-ultraviolet light, including infrared light, into the eye of the subject; or before or during directing the ultraviolet light into the eye of the subject, contacting the eye of the subject with hypochlorous acid;
locating an infection area of the eye of the subject and directing the ultraviolet light onto the infection area; or
locating and mapping an infection area of the eye of the subject by directing the non-ultraviolet light into the eye of the subject and changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof; or
wherein the housing contains a processor,
wherein the processor is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof, and
changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.10 second to about 2.0 minutes by executing a machine-readable code; or
wherein the housing contains a processor,
wherein the processor is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof, and
changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.10 second to about 2.0 minutes by transmitting a signal from the processor to an actuator,
wherein the actuator is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof.

### Claim 12 (depends on 9)

The method of claim 9, wherein the housing contains a processor,
diagnosing the corneal infection by;
directing the non-ultraviolet light into the eye of the subject,
detecting a reflected light from the eye of the subject in the camera module, and
gathering reflected light data by measuring a reflected wavelength, a reflected intensity, and a reflected light position within an area of the eye of the subject,
comparing the reflected light data to a database of corneal infections; and
forming a diagnosis by comparing the reflected light data to a type of corneal infection; or
forming an infection area data map of the eye by comparing the reflected light data to normal eye data, a database of corneal infections, or both; or
any combination thereof.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
after forming the diagnosis,
changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, based on the reflected light data, the type of corneal infection, or both; or
after forming the infection area map,
directing from about 50% to 100% of the ultraviolet light onto a mapped infection area of the eye of the subject, wherein the mapped infection area of the eye corresponds to or matches the infection area data map; or
any combination thereof.

### Claim 14 (depends on 9)

The method of claim 9, further comprising:
before, during, or after directing the ultraviolet light into the eye of the subject, directing the non-ultraviolet light into the eye of the subject; or
locating an abraded area of the eye of the subject and directing the ultraviolet light, infrared light, or both, onto the abraded area; or
locating an abraded area of the eye of the subject by directing the non-ultraviolet light into the eye of the subject and changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, the infrared wavelength, the infrared intensity, or the infrared angle of incidence, or any combination thereof, or
wherein the housing contains a processor,
wherein the processor is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof, and
changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.10 second to about 2.0 minutes by executing a machine-readable code; or
wherein the housing contains a processor,
wherein the processor is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof, and
changing the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, during an adjustment duration of from about 0.10 second to about 2.0 minutes by transmitting a signal from the processor to an actuator,
wherein the actuator is operatively connected to the ultraviolet light source, the non-ultraviolet light source, the camera module, or the eye module, or any combination thereof.

### Claim 15 (depends on 1)

The therapeutic device of claim 1,
wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes mounted around an eye adapter interior surface of the eye module, or mounted within the housing and directed toward the light source opening, or both; and
wherein two or more ultraviolet light emitting diodes of the array of ultraviolet light emitting diodes are configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, by turning on or off; or
wherein the ultraviolet light source includes an array of ultraviolet light emitting diodes and a non-ultraviolet light source mounted around an eye adapter interior surface of the eye module, or mounted within the housing and directed toward the light source opening, or both; and
wherein two or more ultraviolet light emitting diodes of the array of ultraviolet light emitting diodes are configured to change the ultraviolet wavelength, the ultraviolet intensity, or the ultraviolet angle of incidence, or any combination thereof, by turning on or off.
